Old, young – does it matter?

31 October 2016 1

Not so long ago, research protocols excluded older cancer patients based on chronologic age. Now they exclude patients with comorbidities, and as most older patients suffer additional ailments, they do not fit the protocols. But [more]

Tipping the balance

5 January 2016 0

Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]


1 January 2014 0

Selected reports edited by Janet Fricker Clinical trials lead to cost savings => British Journal of Cancer On average, non-commercial oncology clinical trials are associated with small excess treatment costs compared to the standard of [more]

1 2